Cargando…

Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice

The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Bemt, Lisette, van den Nieuwenhof, Lotte, Rutjes, Anne, van der Meer, Victor, Stege, Gerben, Wensing, Michel, Teichert, Martina, Schermer, Tjard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547069/ https://www.ncbi.nlm.nih.gov/pubmed/33037200 http://dx.doi.org/10.1038/s41533-020-00198-5

Ejemplares similares

Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort study
por: Teichert, Martina, et al.
Publicado: (2014)

Primary care cohort study in the sequence of diagnosing chronic respiratory diseases and prescribing inhaled corticosteroids
por: Geraets, Ilja, et al.
Publicado: (2018)

Using the DOSE index to predict changes in health status of patients with COPD: a prospective cohort study
por: Rolink, Myrte, et al.
Publicado: (2013)

Multidimensional prognostic indices for use in COPD patient care. A systematic review
por: van Dijk, Wouter D, et al.
Publicado: (2011)

Chronic comorbid conditions and asthma exacerbation occurrence in a general population sample
por: Baljet, Emma, et al.
Publicado: (2023)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Effects of Adherence to an mHealth Tool for Self-Management of COPD Exacerbations
por: Bischoff, Erik W M A, et al.
Publicado: (2023)

Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial
por: Schermer, Tjard R., et al.
Publicado: (2018)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

PELICAN: A quality of life instrument for childhood asthma: Study Protocol of two Randomized Controlled Trials in Primary and Specialized Care in the Netherlands
por: van Bragt, Stephanie, et al.
Publicado: (2012)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)

Withdrawal of Inhaled Corticosteroids in Patients with COPD – A Prospective Observational Study
por: Nielsen, Anne Orholm, et al.
Publicado: (2021)

How does asthma influence the daily life of children? Results of focus group interviews
por: van den Bemt, Lisette, et al.
Publicado: (2010)

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
por: Vogelmeier, Claus, et al.
Publicado: (2017)

A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
por: Patel, Smit, et al.
Publicado: (2022)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
por: Vasbinder, Erwin C, et al.
Publicado: (2016)

Diagnostic accuracy of pre-bronchodilator FEV(1)/FEV(6) from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study
por: van den Bemt, Lisette, et al.
Publicado: (2014)

Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
por: Choudhury, Aklak B, et al.
Publicado: (2007)

Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology
por: Nadeem, Nighat J, et al.
Publicado: (2011)

Een patiënt met COPD tijdens de COVID-19-pandemie
por: van den Bemt, Lisette, et al.
Publicado: (2020)

Age- and sex-specific prevalence of chronic comorbidity in adult patients with asthma: A real-life study
por: Veenendaal, Mathijs, et al.
Publicado: (2019)

Perceptions of COPD patients of the proposed withdrawal of inhaled corticosteroids prescribed outside guidelines: A qualitative study
por: Gilworth, Gill, et al.
Publicado: (2019)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
por: Jo, Taisuke, et al.
Publicado: (2020)

Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
por: Harries, Timothy H, et al.
Publicado: (2019)

A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management
por: Micheletto, Claudio, et al.
Publicado: (2019)

One More Time: The Impact of Inhaled Corticosteroid Withdrawal on IMPACT
por: Han, MeiLan K., et al.
Publicado: (2020)

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids
por: van den Berge, Maarten, et al.
Publicado: (2021)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
por: Magnussen, Helgo, et al.
Publicado: (2021)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD
por: Kim, Sae Ahm, et al.
Publicado: (2016)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pqkl3jgq343gmlm94r6kva77bv